Company
BridgeBio Oncology Therapeutics (BBOT)
BridgeBio Oncology Therapeutics (BBOT) is a clinical-stage biopharmaceutical company advancing a next generation pipeline of novel small molecule therapeutics targeting RAS and PI3K malignancies. Initially formed as a subsidiary of BridgeBio Services, BBOT completed a $200M private financing with external investors in 2024 with the goal of improving outcomes for patients with cancers driven by the two most prevalent oncogenes in human tumors.
For more information visit bridgebiooncology.com.
Open roles
1
live now
New today
0
last 24 hours
Worldwide remote
0
from anywhere
Departments
1
hiring across
Is BridgeBio Oncology Therapeutics (BBOT) hiring?
Yes — BridgeBio Oncology Therapeutics (BBOT) has 1 open jobs on JobsRadar right now. The board was last refreshed on July 25, 2026 at 09:36 UTC.
0
roles opened in the last 30 days
New roles opened per month over the past year.
0
0
Frequently asked questions
- Is BridgeBio Oncology Therapeutics (BBOT) hiring?
- Yes. BridgeBio Oncology Therapeutics (BBOT) has 1 open jobs on JobsRadar as of July 25, 2026.
- What roles is BridgeBio Oncology Therapeutics (BBOT) hiring for?
- BridgeBio Oncology Therapeutics (BBOT) is hiring for roles in MSL.
- How current are these listings?
- Every listing comes straight from the employer’s own careers system and is re-checked three times a day. This page was last updated on July 25, 2026 at 09:36 UTC.